◀ Back to HDAC3
CDK5 — HDAC3
Text-mined interactions from Literome
Trivedi et al., J Biol Chem 2008
(Cardiomegaly...) :
Hdac3 overexpression
inhibits several
cyclin dependent kinase inhibitors, including Cdkn1a, Cdkn1b, Cdkn1c, Cdkn2b, and Cdkn2c
Veliz et al., Cancer Control 2012
(Leukemia, Lymphocytic, Chronic, B-Cell...) :
These investigational agents include rituximab, alemtuzumab, ofatumumab, bendamustine, high-dose methylprednisolone, lenalidomide, lumiliximab,
cyclin dependent kinase inhibitors, small modular immunopharmaceuticals, Bcl-2 inhibitors, and
histone deacetylase inhibitors